펩티드 치료제 시장은 2019년 248억 7,855만 달러였으며 2027년에는 500억 315만 달러에 이를 것으로 예상됩니다. 2020년부터 2027년까지 CAGR 9.2%로 성장할 것으로 예상됩니다.
펩타이드는 중요한 생물학적 활동에서 두드러진 역할을 하는 자연 발생 생물학적 분자입니다. 만성 질환 치료를 위한 새로운 펩타이드를 개발하기 위해 제약 연구 개발(R&D)에 광범위한 노력을 기울였습니다. 최근 몇 년 동안 7000개 이상의 자연 발생 펩티드가 확인되었으며, 이는 신경 전달 물질, 호르몬, 이온 채널 리간드 및 성장 인자로 작용하여 다양한 인간 생리를 촉진합니다. 펩타이드 치료제 시장의 성장은 주로 펩타이드 치료제에 대한 투자 증가와 대사 장애 및 전염병의 유병률 증가에 기인합니다. 그러나 펩타이드 치료제 시장 성장의 운영 한계.
COVID-19 백신 개발을 위한 펩타이드 분자의 활용 증가는 시장 성장에 긍정적인 영향을 미칠 것으로 추정됩니다. 또한 COVID-19 백신 개발을 위한 펩타이드 사용에 대한 정부 당국의 광범위한 지원은 펩타이드 채택에 대한 잠재적 기회를 제공하여 결국 펩타이드 치료제 시장의 성장을 가속화할 것으로 예상됩니다.
수익성 펩타이드 치료제 시장의 지역
시장 통찰력
대사 장애 및 전염병의 유병률 증가는 펩타이드 치료제 시장 성장을 주도합니다.
대사 및 전염병의 유병률 증가는 하나입니다. 펩타이드 치료제 시장을 주도할 것으로 예상되는 눈에 띄는 요인 중. 예를 들어, 2020년 질병통제예방센터(CDC)에서 발표한 데이터에 따르면 미국에서 약 3,420만 명이 당뇨병을 앓고 있었습니다. 또한 같은 연구에 따르면 당뇨병의 유병률은 지난 수십 년에 비해 지속적으로 증가하고 있습니다. 또한 2020년 CDC에서 발표한 연구에 따르면 미국에서 매년 약 400명의 아기가 혈우병 진단을 받습니다. 또한 2019년 NIH에서 발표한 연구에 따르면 겸상 적혈구 빈혈은 매년 미국에서 약 100,000명, 전 세계적으로 100만 명에게 영향을 미칩니다. 또한 2020년 국제암연구소(International Agency for Research on Cancer)에서 실시한 연구에 따르면 전 세계적으로 약 1,930만 명이 암을 앓고 있다고 합니다. 또한 같은 연구에 따르면 암은 전 세계적으로 약 천만 명의 사망을 초래했습니다. 게다가 2020년 세계보건기구(WHO)가 발표한 자료에 따르면 심혈관 질환은 매년 전 세계적으로 약 1,790만 명의 사망 원인이 되고 있다. 신경 질환, 암 및 당뇨병과 같은 바이러스 감염 및 만성 질환의 치료를 위한 펩타이드 요법의 적용 가능성은 탁월한 치료 대안 중 하나로 펩타이드 요법의 채택을 이끌 것으로 예상됩니다. 이것은 차례로 예측 기간 동안 펩타이드 치료제 시장의 성장을 촉진할 것입니다. 예를 들어, 2020년 10월 임상 단계 생명 공학 회사인 CohBar, Inc.는 CB5138 펩타이드 및 Nintedanib에 대한 긍정적인 연구 결과를 발표했습니다. 이 회사는 특발성 폐섬유증 치료를 위한 CB5138 펩타이드와 닌테다닙 조합의 효능을 평가하고 있습니다.
유형 기반 통찰력
펩타이드 치료제 시장은 유형에 따라 혁신적이고 제네릭. 혁신적인 부문은 2019년에 시장에서 더 큰 점유율을 차지했습니다. 그러나 제네릭 부문은 예측 기간 동안 더 높은 CAGR을 기록할 것으로 추정됩니다.
펩티드 치료제 시장, 유형별 - 2019년 및 2027년
관리 기반 통찰력의 경로
펩티드 치료제 시장은 투여 경로에 따라 비경구, 점막, 경구, 폐 등으로 구분됩니다. 비경구 부문은 2019년 시장에서 가장 큰 점유율을 차지했습니다. 그러나 경구 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 추정됩니다.
합성 기술 기반 통찰력
합성 기술을 기반으로 펩타이드 치료제 시장은 고체상으로 세분화됩니다. 펩타이드 합성(SPPS), 액상 펩타이드 합성(LPPS) 및 하이브리드 기술. 고체상 펩타이드 합성(SPPS) 부문은 2019년 시장에서 가장 큰 점유율을 차지했습니다. 그러나 하이브리드 기술 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 추정됩니다.
응용 기반 통찰력
응용 프로그램을 기반으로 펩타이드 치료제 시장은 암, 대사 장애로 분류됩니다. , 심혈관 장애, 호흡기 장애, 통증 및 피부과. 암 부문은 2019년에 시장에서 가장 큰 점유율을 차지했습니다. 그러나 대사 장애 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 추정됩니다.
전략적 통찰력
펩티드 치료제 시장 참여자들은 변화에 부응하기 위해 제품 혁신 전략을 눈에 띄게 채택하고 있습니다.
펩티드 치료제 시장 - 유형별
- 혁신적
- 제네릭
펩티드 치료제 시장 - 투여 경로별
- 비경구
- 점막
- 경구
- 폐
- 기타
펩티드 치료제 시장 - 합성 기술별
- 고체상 펩티드 합성(SPPS)
- LPPS(액체상 펩티드 합성)
- 하이브리드 기술
응용 분야별 펩티드 치료제 시장
- 암
- 암
- 대사 장애
- 심혈관 장애
- 호흡기 장애
- 통증
- 피부과
< p>펩티드 치료제 시장 – 지역별
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 프랑스
- 독일
- 이탈리아
- 영국
- 스페인
- 기타 유럽
li>
- 아시아 태평양(APAC)
- 중국
- 인도
- 한국
- 일본
- 호주
- 기타 APAC
- 중동 및 아프리카(MEA)
- 남아프리카
- 사우디아라비아
- UAE
- 나머지 MEA
- 중남미(SCAM)
- 브라질
- 아르헨티나
- 나머지 SCAM
회사 프로필
- Eli Lilly 및 회사
- Amgen Inc.
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Polypeptide Group
- EVER Pharma GmbH
- Bristol-Myers Squibb Company
- Novo Nordisk A/S
- Sanofi
- AstraZeneca PLC
- Glaxosmithkline PLC
li>
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The peptide therapeutics market majorly consists of the players such as Eli Lilly and Company, Amgen Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Polypeptide Group, EVER Pharma GmbH, Bristol-Myers Squibb Company, Novo Nordisk A/S, Sanofi, AstraZeneca PLC, and Glaxosmithkline PLC amongst others.
Peptides are naturally occurring biological molecules that play a prominent role in important biological activities. There are extensive efforts have been taken in pharmaceutical research and development (R&D) to innovate new peptides for the treatment of chronic conditions. Over 7000 naturally occurring peptides have been identified in recent years, which have crucial roles in human physiology, including actions as neurotransmitters, hormones, ion channel ligands, and growth factors, amongst others.
The growth of the market is attributed to some key driving factors such as growing investments on peptide therapeutics and increasing prevalence of metabolic and infectious diseases.
The List of Companies - Peptide Therapeutics Market
- Eli Lilly and Company
- Amgen Inc.
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Polypeptide Group
- EVER Pharma GmbH
- Bristol-Myers Squibb Company
- Novo Nordisk A/S
- Sanofi
- AstraZeneca PLC
- Glaxosmithkline PLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)